Enhancing outcomes with evidence-based testing

We offer a broad selection of tests designed for rapid identification and in-depth characterization of causative agents of infectious disease. A menu of testing assays — including culture techniques, immunoassay, antimicrobial susceptibility testing, and molecular methods — rapidly detect, identify, and characterize pathogens to expedite diagnosis. Utilization of algorithmic, evidence-based approaches minimizes unnecessary testing while enhancing diagnosis and treatment.

Featured testing available through Mayo Clinic Laboratories:

HIVQN | HIV-1 RNA Detection and Quantification, Plasma

HIVPR | HIV-1 Genotypic Drug Resistance to Protease and Reverse Transcriptase Inhibitors, Plasma

HIVI | HIV-1 Genotypic Integrase Inhibitor Drug Resistance, Plasma

HIVP | HIV-1 DNA and RNA Qualitative Detection by PCR, Plasma

SFUNG | 1,3-Beta-D-Glucan (Fungitell), Serum

HPFRP | Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR, Feces

Featured testing available through American Hospital Dubai:

American Hospital Dubai testing is orderable as code ZW158, Miscellaneous American Hospital Dubai, in the testing catalog.

Sexual health profile by polymerase chain reaction (PCR)

HEP B Surface Ab (HBs Total)

HEP B Surface Ag (HBs Total)

HEP B Core Ab

HEP C Ab (HCV)

HIV P24 Ag

QuantiFERON-TB Gold Plus, Blood

Learn more about infectious disease testing at Mayo Clinic Laboratories.

Contact us